Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $180,233 | 56 | 52.3% |
| Food and Beverage | $64,744 | 904 | 18.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,297 | 13 | 12.6% |
| Travel and Lodging | $36,589 | 73 | 10.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $19,800 | 10 | 5.7% |
| Education | $173.00 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Acutus Medical, Inc. | $126,022 | 132 | $0 (2023) |
| Abbott Laboratories | $78,187 | 273 | $0 (2024) |
| BIOTRONIK INC. | $37,884 | 118 | $0 (2023) |
| Medtronic, Inc. | $36,079 | 38 | $0 (2024) |
| CardioFocus, Inc. | $18,841 | 83 | $0 (2024) |
| CVRx, Inc. | $16,188 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $14,323 | 37 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $2,706 | 22 | $0 (2024) |
| Biosense Webster, Inc. | $2,704 | 46 | $0 (2024) |
| Boston Scientific Corporation | $2,294 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59,036 | 191 | Medtronic, Inc. ($36,010) |
| 2023 | $21,321 | 128 | Abbott Laboratories ($10,459) |
| 2022 | $66,529 | 170 | Abbott Laboratories ($31,741) |
| 2021 | $45,775 | 136 | Abbott Laboratories ($22,192) |
| 2020 | $65,027 | 106 | Acutus Medical, Inc. ($58,555) |
| 2019 | $53,894 | 103 | Acutus Medical, Inc. ($37,297) |
| 2018 | $12,225 | 111 | Janssen Pharmaceuticals, Inc ($3,458) |
| 2017 | $21,029 | 115 | Janssen Pharmaceuticals, Inc ($10,581) |
All Payment Transactions
1,060 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $36.34 | General |
| Category: Electrophysiology | ||||||
| 12/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/19/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: DEVICES | ||||||
| 12/19/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: DEVICES | ||||||
| 12/18/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: Structural Heart | ||||||
| 12/18/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $170.22 | General |
| Category: Structural Heart | ||||||
| 12/13/2024 | Medtronic, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $21,245.00 | General |
| 12/13/2024 | Medtronic, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $31.54 | General |
| Category: Cardiovascular | ||||||
| 12/13/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Electrophysiology | ||||||
| 12/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/13/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: Electrophysiology | ||||||
| 12/13/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: Electrophysiology | ||||||
| 12/12/2024 | Medtronic, Inc. | AFFERA MAPPING SYSTEM (Device) | Food and Beverage | In-kind items and services | $195.00 | General |
| Category: Ablation | ||||||
| 12/12/2024 | Medtronic, Inc. | AFFERA MAPPING SYSTEM (Device) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: Ablation | ||||||
| 12/12/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Ablation | ||||||
| 12/11/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $56.55 | General |
| Category: Cardiovascular Device | ||||||
| 12/05/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $136.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | Abbott Laboratories | SENSITHERM MULTI (Device) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Electrophysiology | ||||||
| 12/04/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: DEVICES | ||||||
| 12/02/2024 | Abbott Laboratories | ENSITE PRECISION (Device) | Food and Beverage | In-kind items and services | $66.41 | General |
| Category: Electrophysiology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: DEVICES | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $32.28 | General |
| Category: Cardiovascular | ||||||
| 11/15/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $9,382.11 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 3,643 | 7,556 | $2.5M | $461,174 |
| 2022 | 55 | 4,152 | 12,822 | $3.0M | $676,665 |
| 2021 | 56 | 5,044 | 18,782 | $3.5M | $793,739 |
| 2020 | 52 | 4,451 | 18,323 | $2.7M | $621,715 |
All Medicare Procedures & Services
204 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 277 | 281 | $1.3M | $186,261 | 14.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 341 | 585 | $111,150 | $37,421 | 33.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 255 | 260 | $280,800 | $35,069 | 12.5% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 44 | 45 | $213,525 | $33,158 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 213 | 297 | $65,340 | $26,757 | 41.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 78 | 309 | $32,445 | $14,831 | 45.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 62 | 315 | $37,800 | $11,748 | 31.1% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 174 | 181 | $21,720 | $11,080 | 51.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 98 | 157 | $46,315 | $9,808 | 21.2% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 275 | 477 | $36,830 | $9,317 | 25.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 314 | 402 | $34,170 | $9,284 | 27.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 27 | 176 | $22,880 | $6,675 | 29.2% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 277 | 281 | $19,670 | $5,628 | 28.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 24 | 143 | $22,880 | $5,589 | 24.4% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 12 | 12 | $26,940 | $4,881 | 18.1% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 137 | 173 | $34,600 | $4,844 | 14.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 91 | 91 | $25,025 | $4,832 | 19.3% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 111 | 117 | $9,360 | $4,166 | 44.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 71 | 104 | $16,640 | $4,053 | 24.4% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 41 | 46 | $11,500 | $3,500 | 30.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 17 | 68 | $6,120 | $3,270 | 53.4% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 33 | 36 | $9,720 | $3,037 | 31.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 45 | 45 | $18,900 | $2,848 | 15.1% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 23 | $7,705 | $2,409 | 31.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 175 | 224 | $17,920 | $2,342 | 13.1% |
About Dr. Arjun Gururaj, MD
Dr. Arjun Gururaj, MD is a Cardiovascular Disease healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407801624.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arjun Gururaj, MD has received a total of $344,836 in payments from pharmaceutical and medical device companies, with $59,036 received in 2024. These payments were reported across 1,060 transactions from 38 companies. The most common payment nature is "Consulting Fee" ($180,233).
As a Medicare-enrolled provider, Gururaj has provided services to 17,290 Medicare beneficiaries, totaling 57,483 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 204 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Las Vegas, NV
- Active Since 05/24/2006
- Last Updated 04/14/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1407801624
Products in Payments
- ADVISOR (Device) $20,638
- Barostim Neo System (Device) $16,188
- HeartLight System (Device) $14,599
- XARELTO (Drug) $14,323
- EnSite Precision Cardiac Mapping System (Device) $13,695
- ENSITE PRECISION (Device) $8,352
- NA (Device) $8,020
- Advisor Catheter (Device) $5,947
- AMPLATZER AMULET (Device) $4,483
- AVEIR (Device) $2,394
- TactiCath Quartz CFA Catheter (Device) $2,166
- Ablation Therapy Hardware (Device) $1,916
- Carto 3 System (Device) $1,872
- remede System (Device) $1,430
- PULSESELECT (Device) $1,400
- Optimizer (Device) $1,356
- Sentus (Device) $1,129
- BIOMONITOR (Device) $1,027
- OPTIMIZER (Device) $1,010
- VIEWMATE (Device) $937.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Las Vegas
Dr. Cres Miranda, Md, MD
Cardiovascular Disease — Payments: $1.1M
Dr. Claudio Bonometti, M.d, M.D
Cardiovascular Disease — Payments: $199,383
Mr. Nayab Zafar, M.d, M.D
Cardiovascular Disease — Payments: $140,841
Branavan Umakanthan, D.o, D.O
Cardiovascular Disease — Payments: $116,213
Niuton Koide, Md, MD
Cardiovascular Disease — Payments: $112,192
William Chu, M.d, M.D
Cardiovascular Disease — Payments: $109,997